Acute Myocardial Infarction and Percutaneous Coronary Intervention: What does the Epidemiological Data of the Last Years Indicate?

Background: ST-segment elevation acute myocardial infarction (STEMI) is a pathological process that involves cardiac muscle tissue death. Intravenous thrombolysis with fibrinolytics or primary percutaneous coronary intervention (PCI), an invasive technique, can be performed for tissue revascularization. PCI has been preferred as compared to non-invasive methods, although few studies have described its use in Brazil. Objectives: The aim of the present study was to analyze data on the use of primary PCI and investigate the relevance of hospitalizations for the treatment of STEMI in the country. Methods: A descriptive, cross-sectional analysis of data from the Brazilian Unified Health system (SUS) Department of Informatics (DATASUS) from 2010 to 2019 was conducted. Results: Hospitalizations for STEMI represented 0.6% of all hospital admissions in Brazil in the analyzed period, 0.9% of hospital costs, and 2.1% of deaths. The number of hospitalizations due to STEMI was 659,811, and 82,793 for PCIs. Length of hospital stay was 36.0% shorter and mortality rate was 53.3% lower in PCI. The mean cost of PCI was 3.5-fold higher than for treatment of STEMI. Conclusions: Data on hospitalizations for STEMI treatment in Brazil revealed high hospitalization and mortality rates, elevated costs, and long hospital stay. Although primary PCI is a more expensive and less used technique than other methods, it can reduce the length of hospital stay and mortality in the treatment of STEMI.

of hospitals by ownership (public -federal, state, and municipal hospitals, or private (contracted by SUS, philanthropic, and union hospitals).
All procedures were classified according to the codes included in the SUS table, maintaining the original nomenclature: 0303060190 -Treatment of Acute Myocardial Infarction; 0303060280 -Treatment of Acute Coronary Syndrome; 0303060204 -Treatment of Arterial Failure with Critical Ischemia; 0406030049 -Primary Coronary Angioplasty. Codes 0303060280 and 0303060204 were considered as Ischemic Syndromes.
Since the information was obtained from a public domain database, this study did not need ethics committee approval.

Results
Data obtained for the period between 2010 and 2019 are described in Table 1.
The rate of hospital admissions over the years can be viewed in the graph below ( Figure 1).
When analyzing the data related to the treatment of STEMI, the year with the highest number of admissions was 2019, with 80,516 hospitalizations, which represented 12.2% of the total. Overall, there was a 40.2% growth between 2010 and 2019. The federal state with the highest number of hospitalizations was São Paulo, with 198,593 admissions, corresponding to 30.1% of all hospital admissions for the treatment of STEMI in the country.
Among the total admissions for STEMI treatment, only 12.5% were for primary referral for PCI. The highest number of procedures was registered in the year 2019, with 11,099 hospitalizations (13.4% of the total number of hospital admissions for primary PCI). A 49% increase in the use of this technique was observed in the analyzed period. The federal state with the highest number of hospitalizations was also São Paulo, with 2,329 admissions, which corresponds to 21.2% of the total.
Regarding the type of hospital (whether public or private), in 46.7% of cases the type of hospitalization for the treatment of STEMI was not recorded; 27.4% (n=180,507) admissions occurred in public hospitals, and 25.9% (n=170,939) of hospitalizations took place in the private hospitals. Data on the use of primary PCI indicated that most procedures were performed in the private sector (31.1%; n=25,717), while 15.3% (n=12,699) took place in the public sector. Note that in 44,377 (53.6%) cases, the type of hospital was not recorded. percutaneous coronary interventions (PCIs)³ can be carried out.
According to the literature, primary PCI has greater efficacy and better results than fibrinolysis, especially if performed within the first 90 minutes of symptom onset. Despite the similarity with fibrinolytics regarding the need for early intervention for good results, the invasive technique has been preferred over the noninvasive method,⁴ given its association with higher rates of recanalization of the culprit vessel, lower rates of reocclusion and bleeding, in addition to improved ventricular function and survival.⁴ -⁷ However, progress has been made in the treatment for the stabilization of atherosclerotic plaques in the coronary arteries. Studies such as COURAGE2, ISCHEMIA, and CAPTIM have reported similar results concerning drug therapy, percutaneous intervention, and revascularization surgery in prospective follow-up of patients after the acute period.⁸ , ⁹ Thus, the main aim of this study was to analyze data on the use of primary PCI as an alternative in STEMI episodes compared with pharmacological treatment in Brazil. The scarcity of data and the importance of this issue justify studies for a better understanding of the Brazilian reality in this regard. Another objective was to investigate factors related to hospitalizations for the treatment of STEMI -total number of hospitalizations, hospitalization costs, and in-hospital mortality.

Methods
This was a descriptive, cross-sectional study. Data were collected from the "Hospital Admission Authorization" (AIH) form, a document filled out by the physician upon hospital admission recorded in the Hospital Information System (SIH/SUS), available in the free online database of the Brazilian Unified Health System (SUS) Department of Informatics (DATASUS). Data were collected from January to March 2020 and tabulated and analyzed using the TABNET program.
To perform an analysis of a 10-year period, data between January 2010 and December 2019 were examined. We evaluated total hospital admissions in Brazil and hospitalizations for the treatment of ischemic syndromes, STEMI, and for referral for primary coronary angioplasty. The following variables were collected from the records: number of admissions, total hospitalization costs, average cost per admission, mean length of hospital stay, number of deaths, mortality rate, and categories The mean length of hospital stay for primary PCI was 36% shorter compared with the duration of hospitalizations for the treatment of STEMI.
Hospital costs for the treatment of STEMI increased by 62.4% during the analyzed period. The highest hospital costs were observed in São Paulo state, BR$378,783,670.64, corresponding to 31.1% of the total national costs, which, in turn, showed a 10.1% increase over the years. Total hospital expenses for PCI admissions corresponded to 43.9% of the total costs for the treatment of STEMI, which showed a 101.83% increase in the analyzed period. Again, the federal state with the highest costs was São Paulo, with BR$120,791,951.46, accounting for 14.02% of the costs with PCI in the country. The average cost per PCI procedure was 3.5-fold higher than that for STEMI treatment, with a 13.87% increase during the analyzed period.
Regarding mortality rate, the national in-hospital mortality rate for treatment of STEMI reduced by 15.2% in the period from 2010 to 2019. As for primary PCI, inhospital mortality rate was 53.33% lower than for STEMI treatment, with a reduction of 17.2% in the analyzed period.
Of the 1,895 types of hospital procedures described

Discussion
The data obtained herein evidenced the discrepancy between the numbers of hospital admissions for the treatment of STEMI and for primary coronary angioplasty in the country. Although the number of isolated primary PCI procedure was low, the use of this technique considerably increased in Brazil during the analyzed period, with a growth of 49% from 2010 to 2019. Such increment can be related to the greater support from scientific literature, investments in the field, refinement of the technique, as well as the larger availability of technology for its use in the country.¹º , ¹¹ Nevertheless, this number corresponds to a small percentage of all hospitalizations for the treatment of STEMI during the analyzed period (12.54%). Improvements in the technique and technology, such as the adoption of drug-eluting stents and more potent antiplatelet drugs (including surface glycoprotein IIb/ IIIa receptor inhibitors), also justify the increase in hospitalization costs and supplemental health services in angioplasty interventions.¹² These advances are accompanied by increasing rates of therapeutic success and reduced mortality.¹³ When compared to fibrinolytics, primary PCI is associated with better short-and long-term clinical outcomes, including greater ability to reestablish coronary flow, and reduced rates of recurrent ischemia, reinfarction, and stroke. Thus, this is the treatment of choice when there is the possibility of transferring the patient to a hospital capable of performing this procedure,⁵ , ¹⁴ -¹⁷ and should be preferably performed within 90 minutes after the diagnosis of STEMI. 5,[16][17][18] North American studies with registries from the National Registry of Myocardial Infarction (NRMI) 1, 2, and 3, reported a significant increment in the use of angioplasty compared with fibrinolytics, and a concomitant decrease in morbidity and mortality of Int J Cardiovasc Sci. 2022; 35 (2), [184][185][186][187][188][189][190] patients with sustained STEMI. This is related to advances in technology and interventional cardiology, justified by investments in technology and greater experience of the medical teams in countries like the United States. 19 The growing use of primary PCI in Brazil has been observed since the late 1990s.¹² In a Brazilian study published in 2010, Piegas and Haddad 11 conducted a data survey and showed an increasing performance of PCI in Brazil, with some referral centers presenting mortality rates comparable to international values.¹¹ , ¹ 4 In the study by Widimsky et al.,20 conducted in Europe between 2007 and 2008, 37% to 93% of STEMI patients received some kind of reperfusion treatment, varying from country to country, with primary PCI as the most prevalent therapy in most countries.² 1 In a study carried out in the United States between 2007 and 2009 with patients with infarction, primary PCI was adopted in 81% of the cases in which reperfusion treatment was applied.²¹ According to the ACCEPT trial, carried out in Brazil between 2011 and 2012, among the 846 patients admitted in hospital centers with STEMI, 83.3% (n=705) received reperfusion therapy, with 10% (71) being treated with thrombolytic agents and 90% (634) with primary angioplasty.²² Considering that the present study was a national analysis covering different tertiary care hospitals, the collected data indicate that 12.54% of the hospitalizations for STEMI treatment were for primary angioplasty, evidencing a possible contrast in relation to the ACCEPT trial.
Regarding mortality due to primary coronary angioplasty, Canadian studies analyzing data between 2000 and 2005 showed a mortality rate of 1.4%. 19 Meanwhile, in North American studies carried out between 1998 and 2000, the mortality rate was 0.78%,²³ whereas other studies conducted in the same country between 2004 and 2017 revealed a mortality rate of 1.27%. 24 Data from Brazilian studies reported mortality rates between 2% and 6%, 11,25-30 however, the present study found national values close to 6.8%.
In contrast with the findings commonly described in the literature regarding morbidity and mortality rates of the two main revascularization techniques, studies such as CAPTIM, in France, and WEST, in Canada, showed that the mortality rates in one year were not different between the groups of patients who received fibrinolytics and those who underwent primary PCI.
The two studies claim that participants who underwent fibrinolysis within two hours of symptom onset had better one-year survival when compared to those who received PCI in the same period; after two hours, no difference was observed.³¹ As for costs, although percutaneous angioplasty represented only 12.5% of hospitalizations for treatment of STEMI, the procedure corresponded to approximately 43.9% of the total expenses. However, the mortality rate in hospital admissions for primary angioplasty (6.8%) was around 53.3% lower than for the treatment of STEMI (14.53%). Therefore, it is possible to correlate primary PCI with lower mortality rates and higher costs. Nonetheless, we cannot rule out that discrepancy in these numbers may have been influenced by disparities in hospital centers.
The obtained data also showed that the mean length of stay of patients treated with angioplasty (5.3 days) was shorter than that registered for the treatment of STEMI (8.3 days). On the other hand, it is of note that the angioplasty procedure is more costly since it requires specific technologies and interventional cardiology team.
Regarding the relevance of hospitalizations for STEMI in the country, in the present study among the 1,895 types of procedures, the treatment of STEMI occupied significant positions in the national ranking of hospital admissions, costs, and deaths. The impact of cardiovascular diseases and, especially, STEMI on death rates and costs in Brazil is well established in the medical literature. In 2009, cardiovascular ischemic syndromes accounted for more than 7% of all deaths in the country and 19% of the total costs with hospitalizations in the SUS budget. 13,[32][33][34] It is important to highlight that there are several limitations regarding the quality of health services in Brazil, which may have influenced the use and effectiveness of different techniques, and hence on data obtained. Among these limitations, the following may be considered: different availability of hemodynamic laboratories; poor coordination of the health network; low efficacy of patient transport; and limited access or low availability of imaging tests, medications, resources, and technologies. 34,35 Another aspect that can also be considered a limitation in this study was the dependence on data and designations attributed by the DATASUS platform to the analyzed categories.

References Conclusion
Based on the collected data, primary coronary angioplasty has been scarcely performed considering all the total number of hospitalizations for the treatment of STEMI. Despite the higher costs, the procedure promotes a shorter hospital stay and a lower mortality rate compared to other treatments for infarction. The significant increase in the use of primary angioplasty (by more than 49% in the past 10 years), concomitant with increases in the cases of STEMI, indicate that this alternative method can be further exploited in Brazil.
The statistical and epidemiological importance of data on STEMI hospitalizations, costs, and mortality rates can assist in measuring the impact of this disease on our society. Thus, the present study is of significant value for public health managers, as well as hospitals and medical teams that apply the PCI technique.
More studies in this field are needed in the country, considering particularities of each region and how health networks are organized to provide PCI for eligible patients in a timely manner and with qualified professionals. From an economic viewpoint, it would be interesting to compare PCI-related costs in Brazil with those in other countries where this technique has been used for a longer time to verify whether there is a trend of cost reduction with the advancement and greater accessibility of the technology required for this intervention.

Potential Conflict of Interest
No potential conflict of interest relevant to this article was reported.

Sources of Funding
There were no external funding sources for this study.

Study Association
This study is not associated with any thesis or dissertation work.

Ethics approval and consent to participate
This article does not contain any studies with human participants or animals performed by any of the authors.